Autism Spectrum Disorder, Developmental and Psychiatric Features in 16p11.2 Duplication

被引：0

作者：

LeeAnne Green Snyder

Debra D’Angelo

Qixuan Chen

Raphael Bernier

Robin P. Goin-Kochel

Arianne Stevens Wallace

Jennifer Gerdts

Stephen Kanne

Leandra Berry

Lisa Blaskey

Emily Kuschner

Timothy Roberts

Elliot Sherr

Christa L. Martin

David H. Ledbetter

John E. Spiro

Wendy K. Chung

Ellen Hanson

机构：

[1] Simons Foundation,Department of Biostatics

[2] Columbia University,Department of Clinical Genetics

[3] Columbia University,Department of Psychiatry and Behavioral Sciences

[4] University of Washington,Department of Pediatrics

[5] Baylor College of Medicine,Thompson Center

[6] University of Missouri,Department of Radiology

[7] Children’s Hospital Philadelphia,Department of Child and Adolescent Psychiatry and Behavioral Sciences

[8] Children’s Hospital Philadelphia,Autism and Developmental Medicine Institute

[9] University of California San Francisco School of Medicine,Developmental Medicine

[10] Geisinger Health System,undefined

[11] Children’s Hospital Boston/Harvard Medical School,undefined

来源：

Journal of Autism and Developmental Disorders | 2016年 / 46卷

关键词：

16p11.2 duplication; Genetics; Neuropsychological; Autism; Intellectual disability; Cognitive;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The 16p11.2 duplication (BP4–BP5) is associated with Autism Spectrum Disorder (ASD), although significant heterogeneity exists. Quantitative ASD, behavioral and neuropsychological measures and DSM-IV diagnoses in child and adult carriers were compared with familial non-carrier controls, and to published results from deletion carriers. The 16p11.2 duplication phenotype ranges widely from asymptomatic presentation to significant disability. The most common diagnoses were intellectual disability, motor delays and Attention Deficit Hyperactivity Disorder in children, and anxiety in adults. ASD occurred in nearly 20 % of child cases, but a majority of carriers did not show the unique social features of ASD. The 16p11.2 duplication phenotype is characterized by wider variability than the reciprocal deletion, likely reflecting contributions from additional risk factors.

引用

页码：2734 / 2748

页数：14

共 1229 条

[1]

Achenbach TM(2001)Advances in empirically based assessment: revised cross-informant syndromes and new DSM-oriented scales for the CBCL, YSR, and TRF: Comment on Lengua, Sadowski, Friedrich, and Fischer Journal of Consulting and Clinical Psychology 69 699-702

[2]

Dumenci L(1995)Controlling the false discovery rate: A practical and powerful approach to multiple testing Journal of the Royal Statistical Society: Series B 57 289-300

[3]

Benjamini Y(2011)Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting Brain Research 1380 42-77

[4]

Hochberg Y(2009)Extending the phenotype of recurrent rearrangements of 16p11.2: Deletions in mentally retarded patients without autism and in normal individuals European Journal of Medical Genetics 52 77-87

[5]

Betancur C(2012)The autism sequencing consortium: Large scale, high throughput sequencing in autism spectrum disorders Neuron 76 1052-1056

[6]

Bijlsma EK(2005)Intergenerational transmission of subthreshold autistic traits in the general population Biological Psychiatry 57 655-660

[7]

Gijsbers AC(2016)Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities JAMA Psychiatry 73 20-30

[8]

Schuurs-Hoeijmakers JH(2014)Synaptic, transcriptional and chromatin genes disrupted in autism Nature 515 209-273

[9]

van Haeringen A(2012)Association between copy number variants in 16p11.2 and major depressive disorder in a German case–control sample American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 159B 263-57

[10]

Fransen van de Putte DE(2016)Maternal modifiers and parent-of-origin bias of the autism-associated 16p11.2 cnv The American Journal of Human Genetics 98 45-203

← 1 2 3 4 5 6 7 8 9 10 →